Renovacor, Inc.
RCORDelisted Dec 1, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799850
Renovacor, Inc. was delisted on Dec 1, 2022; its insiders filed their last Form 4 on Apr 5, 2023; 27 institutions reported holding it in 13F filings for Q3 2022, worth $18.4M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in Renovacor, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- 0 vs. Q1 2022
- Shares held
- 7.91M
- −64.9K (−0.8%) vs. Q1 2022
- Total value
- $16.0M
- −$17.8M (−52.6%) vs. Q1 2022
- New holders
- 2
- 5 more added
- Sold out
- 2
- 6 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RCOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 27 | $18.4M |
| Q2 2022 | 24 | $16.0M |
| Q1 2022 | 24 | $33.8M |
| Q4 2021 | 23 | $58.4M |
| Q3 2021 | 22 | $64.5M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Renovacor, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 69 | $0 | 0.00% | +5+7.8% | Added |
| Tower Research Capital LLC (TRC) | 1,696 | $3.00K | 0.00% | +823+94.3% | Added |
| Wolverine Asset Management LLC | 3,265 | $6.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,120 | $6.00K | 0.00% | +1,228+64.9% | Added |
| State Street Corp | 12,492 | $25.0K | 0.00% | +663+5.6% | Added |
| Murchinson Ltd. | 15,886 | $32.0K | 0.01% | +15,886 | New |
| Northern Trust Corp | 16,861 | $34.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 23,001 | $46.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 31,979 | $65.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 36,097 | $73.0K | 0.00% | +35,480+5,750.4% | Added |
| Bridgeway Capital Management, LLC | 49,900 | $101.0K | 0.00% | +49,900 | New |
| Morgan Stanley | 53,021 | $108.0K | 0.00% | −140.0% | Reduced |
| HRT Financial LP | 91,682 | $185.0K | 0.00% | −11,212−10.9% | Reduced |
| Pura Vida Investments, LLC | 144,925 | $294.0K | 0.05% | −465−0.3% | Reduced |
| 683 Capital Management, LLC | 175,000 | $355.0K | 0.03% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 199,490 | $405.0K | 0.22% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 293,283 | $595.0K | 0.25% | −50,000−14.6% | Reduced |
| Altium Capital Management LP | 388,845 | $788.0K | 0.33% | 00.0% | Unchanged |
| Vanguard Group Inc | 415,758 | $843.0K | 0.00% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 500,000 | $1.01M | 0.08% | 00.0% | Unchanged |
| New Leaf Venture Partners, L.L.C. | 670,689 | $1.36M | 0.88% | −1,599−0.2% | Reduced |
| Sio Capital Management, LLC | 735,908 | $1.49M | 0.59% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,049,014 | $2.13M | 0.00% | −5,392−0.5% | Reduced |
| RTW Investments, LP | 3,000,803 | $6.08M | 0.16% | 00.0% | Unchanged |
| Kepos Capital LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −200−100.0% | Sold out |